|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
28.05.26 - 14:09
|
Verrica Pharmaceuticals to Participate in the Jefferies Global Healthcare Conference (GlobeNewswire EN)
|
|
|
WEST CHESTER, Pa., May 28, 2026 (GLOBE NEWSWIRE) -- Verrica Pharmaceuticals Inc. (“Verrica”) (Nasdaq: VRCA), a therapeutics company developing and commercializing medications for the treatment of dermatological diseases, including skin cancers, today announced that Jayson Rieger, PhD, MBA, President and Chief Executive Officer of Verrica Pharmaceuticals, will present at the Jefferies Global Healthcare Conference....
|
|
|
|
|
13.05.26 - 14:03
|
Verrica Pharmaceuticals to Participate in the H.C. Wainwright 4th Annual BioConnect Investor Conference at NASDAQ (GlobeNewswire EN)
|
|
|
WEST CHESTER, Pa., May 13, 2026 (GLOBE NEWSWIRE) -- Verrica Pharmaceuticals Inc. (“Verrica”) (Nasdaq: VRCA), a therapeutics company developing and commercializing medications for the treatment of dermatological diseases, including skin cancers, today announced that Jayson Rieger, PhD, MBA, President and Chief Executive Officer of Verrica Pharmaceuticals, will present at the H.C. Wainwright 4th Annual BioConnect Investor Conference at NASDAQ....
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
06.05.26 - 07:06
|
New Phase II Study Data from Lytix Biopharma′s Partner Verrica Pharmaceuticals to be Presented at SID 2026 Highlight Potential Abscopal Effects of Ruxotemitide in Basal Cell Carcinoma (Cision)
|
|
|
Oslo, Norway, May 6, 2026 – Lytix Biopharma ASA (“Lytix” or the “Company”) today announced that new Phase II clinical data on ruxotemitide, also known as VP-315, will be presented by its partner Verrica Pharmaceuticals Inc. (“Verrica”) at the 2026 Society for Investigative Dermatology SID) Annual Meeting, taking place May 13–16, 2026, in Chicago, Illinois.
The data suggests a potential abscopal effect of VP-315 in the treatment of basal cell carcinoma (BCC), as evidenced by reductions in the size of untreated, non-injected lesions.
The Phase II data to be presented by Verrica showed:...
|
|
Börsentreff auf Facebook |
Börsentreff auf X |
Börsentreff auf Instagram
